Secret War on Sneaky Lung Bugs: NIH Hides Contract Bids
Published Date: 4/4/2025
Notice
Summary
The National Institute of Allergy and Infectious Diseases is holding a private meeting on May 2, 2025, to review contract proposals for new treatments targeting tough infections called non-tuberculosis mycobacterial infections. This meeting affects researchers and companies competing for funding to develop these medical solutions. The review helps decide who gets money to create better treatments, all while keeping sensitive info under wraps.
Analyzed Economic Effects
2 provisions identified: 1 benefits, 0 costs, 1 mixed.
Closed Review Protects Proprietary Proposals
The National Institute of Allergy and Infectious Diseases will hold a closed meeting on May 2, 2025, from 11:00 a.m. to 1:00 p.m. to review contract proposals. The meeting is closed under 5 U.S.C. 552b(c)(4) and 552b(c)(6) to protect confidential trade secrets, patentable material, and personal information of proposal submitters.
NIH Panel Will Evaluate SBIR NTM Proposals
A special emphasis panel (HHS-NIH-CDC-SBIR PHS 2025-1, Phase I/II, Topic 144) will review and evaluate contract proposals on May 2, 2025, to decide awards for developing treatments for non-tuberculosis mycobacterial (NTM) infections. The panel's review determines which researchers and companies competing for this SBIR funding may receive contracts.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in